Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lower cost sleep apnoea diagnosis feasible:

This article was originally published in Clinica

Executive Summary

Simple nocturnal oximetry measurements are effective for diagnosing sleep apnoea hypopnea syndrome (SAHS) and can avoid the need for expensive and time-consuming polysomnographs, according to Spanish researchers. Reporting in the November edition of Thorax, a team from Hospital Universitario San Juan de Alicante assessed 275 patients with suspected SAHS and diagnosed the condition in 216 cases. The positive predictive value of oximetry was between 97% and 99%, depending on what cut-off points of oxygen desaturation were used. Sensitivity was 63% to 80%, specificity was 89% to 96% and negative predictive value was 38% to 48%.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel